Skip to main content
. 2012 Jul 27;12:87.

Table 2.

treatment outcome following adverse drug reactions (ADRs)

HAART Regimen Treatment changed (%) Treatment maintained (%) P-value
AZT-3TC-NVP 6 (13.3) 5 (23.8) P=0.04
AZT-3TC-EFV 7 (15.6) 8 (38.1)
D4T-3TC-NVP 24 (53.3) 5 (23.8)
D4T-3TC-EFV 7 (15.6) 1 (4.8)
other 1 (2.2) 2 (9.5)
Total 45 (68.2) 21 (31.8)

AZT: Zidovudine, D4T: Stavudine